Event-level impact of Promescent on quality of sexual experience in men with subjective premature ejaculation

Abstract

Promescent is a lidocaine-based ejaculation delaying spray that absorbs into the skin of the penis prior to sexual activity. This article aimed to evaluate the effect of Promescent on the experience of orgasm, ejaculatory latency time and quality of sexual experience (QSE). Additionally, we assessed ease of application of Promescent and the extent to which it enhanced or interrupted the sexual experience. The analytic sample consisted of 91 men with self-reported subjective premature ejaculation who were sent a sample of Promescent and completed a 14-day internet-based prospective daily electronic report. Average ejaculatory latency time was 11.16 min during product use events, compared with 6.81 min during product non-use events. Both members of the couple had an orgasm 65.6% of the time when they used the product, compared with 44.1% when they did not use the product. QSE was significantly improved on product use days (P<0.05). Quality also significantly improved each subsequent time the product was used (P<0.01). The product was reported as easy to use and did not interrupt the sexual experience. Findings suggest that the use of this topical spray significantly improves QSE and perception of partner experience, and that these improve with longer duration of use.

Progresses in pharmaceutical and surgical management of premature ejaculation

“…[71] Some of these drugs have a local anesthetic effect and are, therefore, also used to treat PE. [72,73]…”

The Effects of Steady Freddy, a Lidocaine-Based Pump Spray for the Treatment of Premature Ejaculation (PE)

“…Lidocaine is an amide class local anesthetic that acts via the blockade of voltage-gated sodium channels leading to a reversible blockage of action potential propagation ( Garmon & Huecker, 2022 ). Lidocaine is commonly used as a local and topical anesthetic and was previously used for the treatment of PE in various concentrations ( El-Hamd, 2021 ; Mark & Kerner, 2016 ).…”